| Title |
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2022
|
| DOI | 10.1002/14651858.cd014383.pub2 |
| Pubmed ID | |
| Authors |
Irene Bighelli, Alessandro Rodolico, Spyridon Siafis, Myrto T Samara, Wulf-Peter Hansen, Salvatore Salomone, Eugenio Aguglia, Pierfelice Cutrufelli, Ingrid Bauer, Lio Baeckers, Stefan Leucht |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 5 | 42% |
| United States | 1 | 8% |
| France | 1 | 8% |
| Unknown | 5 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 75% |
| Scientists | 1 | 8% |
| Practitioners (doctors, other healthcare professionals) | 1 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 42 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 12% |
| Other | 3 | 7% |
| Student > Ph. D. Student | 3 | 7% |
| Student > Bachelor | 2 | 5% |
| Lecturer > Senior Lecturer | 1 | 2% |
| Other | 3 | 7% |
| Unknown | 25 | 60% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Nursing and Health Professions | 2 | 5% |
| Psychology | 1 | 2% |
| Sports and Recreations | 1 | 2% |
| Other | 5 | 12% |
| Unknown | 25 | 60% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2023.
All research outputs
#2,693,791
of 25,658,541 outputs
Outputs from Cochrane database of systematic reviews
#5,350
of 13,150 outputs
Outputs of similar age
#56,158
of 431,442 outputs
Outputs of similar age from Cochrane database of systematic reviews
#74
of 128 outputs
Altmetric has tracked 25,658,541 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,150 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,442 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 128 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.